Artemether-lumefantrine
Artemether-lumefantrine (Co-artemether) is an Artemisinin (HY-B0094) -derived combination antimalarial. Artemether-lumefantrine is effective against malaria caused by P. falciparum[1].
Product Specifications
CAS Number
[141204-94-6]
Product Name Alternative
Co-artemether
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Parasite
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Smiles
C[C@@H]1[C@@]2([H])[C@]34[C@](O[C@](OO3)(CC[C@@]4([H])[C@@H](CC2)C)C)([H])O[C@@H]1OC.CCCCN(CCCC)CC(C5=C6C(/C(C7=CC(Cl)=CC=C76)=C\C8=CC=C(C=C8)Cl)=CC(Cl)=C5)O
Molecular Formula
C46H58Cl3NO6
Molecular Weight
827.31
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Stover KR, et al. Artemether-lumefantrine: an option for malaria. Ann Pharmacother. 2012 Apr;46 (4) :567-77.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Plasmodium
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RC229056 10 µg
Sodium Potassium ATPase (ATP1A1) (NM_001160234) Human Tagged ORF Clone
Ask
View Details ![EBLN2 Mouse Monoclonal Antibody [Clone ID: OTI2D5]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
